Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut, USA.
Am J Physiol Renal Physiol. 2010 Mar;298(3):F745-53. doi: 10.1152/ajprenal.00182.2009. Epub 2009 Dec 16.
Na+/H+ exchanger 3 (NHE3) is phosphorylated and regulated by multiple kinases, including PKA, SGK1, and CK2; however, the role of phosphatases in the dephosphorylation and regulation of NHE3 remains unknown. The purpose of this study was to determine whether serine/threonine phosphatases alter NHE3 activity and phosphorylation and, if so, at which sites. To this end, we first examined the effects of calyculin A [a combined protein phosphatase 1 (PP1) and PP2A inhibitor] and okadaic acid (a PP2A inhibitor) on general and site-specific NHE3 phosphorylation. Calyculin A induced a phosphorylation-dependent NHE3 gel mobility shift and increased NHE3 phosphorylation at serines 552 and 605. No change in NHE3 phosphorylation was detected after okadaic acid treatment. An NHE3 gel mobility shift was also evident in calyculin A-treated COS-7 cells transfected with either wild-type or mutant (S552A, S605G, S661A, S716A) rat NHE3. Since the NHE3 gel mobility shift occurred despite mutation of known phosphorylation sites, novel sites of phosphorylation must also exist. Next, we assayed NHE3 activity in response to calyculin A and okadaic acid and found that calyculin A induced a 24% inhibition of NHE3 activity, whereas okadaic acid had no effect. When all known NHE3 phosphorylation sites were mutated, calyculin A induced a stimulation of NHE3 activity, demonstrating a functional significance for the novel phosphorylation sites. Finally, we established that the PP1 catalytic subunit can directly dephosphorylate immunopurified NHE3 in vitro. In conclusion, our data demonstrate that a calyculin A-sensitive phosphatase, most likely PP1, is involved in the regulation and dephosphorylation of NHE3 at known and novel sites.
钠/氢交换体 3(NHE3)可被多种激酶磷酸化和调节,包括蛋白激酶 A(PKA)、血清和糖皮质激素诱导的蛋白激酶 1(SGK1)和蛋白激酶 C 同工酶 2(CK2);然而,磷酸酶在 NHE3 的去磷酸化和调节中的作用仍不清楚。本研究旨在确定丝氨酸/苏氨酸磷酸酶是否会改变 NHE3 的活性和磷酸化,如果是,是在哪些位点。为此,我们首先研究了 calyculin A(一种蛋白磷酸酶 1(PP1)和 PP2A 的联合抑制剂)和 okadaic 酸(一种 PP2A 抑制剂)对一般和特定 NHE3 磷酸化的影响。Calyculin A 诱导 NHE3 的磷酸化依赖性凝胶迁移改变,并增加 NHE3 在丝氨酸 552 和 605 的磷酸化。Okadaic 酸处理后,NHE3 的磷酸化没有变化。Calyculin A 处理的 COS-7 细胞中转染野生型或突变型(S552A、S605G、S661A、S716A)大鼠 NHE3 也出现 NHE3 凝胶迁移改变。由于 NHE3 的凝胶迁移改变发生在已知磷酸化位点的突变之后,因此必须存在新的磷酸化位点。接下来,我们检测了 calyculin A 和 okadaic 酸对 NHE3 活性的影响,发现 calyculin A 诱导 NHE3 活性抑制 24%,而 okadaic 酸无影响。当所有已知的 NHE3 磷酸化位点都发生突变时,calyculin A 诱导 NHE3 活性的刺激,表明新磷酸化位点具有功能意义。最后,我们确定 PP1 催化亚基可以在体外直接使免疫纯化的 NHE3 去磷酸化。总之,我们的数据表明,calyculin A 敏感的磷酸酶,很可能是 PP1,参与了已知和新的磷酸化位点的 NHE3 的调节和去磷酸化。